The impact of HEV-ORF2 genetic diversity on neutralizing antibodies: An In-Silco study toward the development of pan-HEV therapeutics and vaccines

Next Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles